¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"indirect action"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • indirect ophthalmoscope
    µµ»ó°Ë¾È°æ, °Å²Ü´«º¸°³
  • indirect proof
    °£Á¢Áõ¸í(¹ý)
  • indirect retainer
    °£Á¢À¯ÁöÀåÄ¡
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
  • antimicrobial action
    Ç×±ÕÀÛ¿ë
  • antipyretic action
    ÇØ¿­ÀÛ¿ë
  • action
    1. ÀÛ¿ë 2. Ȱµ¿
  • action current
    Ȱµ¿Àü·ù
  • action potential
    Ȱµ¿ÀüÀ§
  • action tremor
    Ȱµ¿¶³¸²
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • absorption action
    Èí¼öÀÛ¿ë
  • amphoteric action
    ¾çÂÊÀÛ¿ë
  • anabolic action
    ÇÕ¼º´ë»çÀÛ¿ë, µ¿È­ÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • indirect antiglobulin test
    °£Á¢Çױ۷κҸ°°Ë»ç
  • indirect direct method
    °£Á¢Á÷Á¢¹ý
  • indirect fluorescent antibody technique
    °£Á¢Çü±¤Ç×ü¹ý
  • indirect fluorescent antibody test
    °£Á¢Çü±¤Ç×ü°Ë»ç
  • indirect immunofluorescence reaction
    °£Á¢¸é¿ªÇü±¤¹ÝÀÀ
  • action
    Ȱµ¿, ÀÛ¿ë
  • absorption action
    Èí¼öÀÛ¿ë
  • action current
    Ȱµ¿Àü·ù
  • action potential
    Ȱµ¿ÀüÀ§
  • action tremor
    Ȱµ¿¶³¸²
  • additive action
    ºÎ°¡ÀÛ¿ë
  • adverse action
    À¯ÇØÀÛ¿ë
  • amphoteric action
    ¾ç¼ºÀÛ¿ë
  • anabolic action
    µ¿È­ÀÛ¿ë
  • antifungal action
    Ç×Áø±ÕÀÛ¿ë
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • indirect complement fixation test
    °£Á¢º¸Ã¼°áÇÕ½ÃÇè
  • indirect contact
    °£Á¢Á¢ÃË.
  • indirect contact infection
    °£Á¢Á¢Ã˰¨¿° <Àü¿°>.
  • indirect direct method
    °£Á¢Á÷Á¢¹ý(ÊàïÈòÁ ïÈÛö).
  • indirect fluorescent antibody technique
    °£Á¢Çü±¤Ç×ü¹ý
  • indirect fracture
    °£Á¢ °ñÀý(ÊàïÈÍéï¹).
  • indirect gonioscopy
    °£Á¢Àü¹æ°¢°æ°Ë»ç
  • indirect hemagglutination =IHA
    °£Á¢ÀûÇ÷±¸ÀÀÁý(¹ÝÀÀ)(¡­îåúìϹëêó¢<Úãëë >).
  • indirect immunodiffusion
    °£Á¢(ÊàïÈ)¸é¿ªÈ®»ê(Øóæ¹üªß¤)
  • indirect immunofluorescence antibody
    °£Á¢¸é¿ªÇü±¤Ç×ü
  • indirect immunofluorescence reaction
    °£Á¢¸é¿ªÇü±¤¹ÝÀÀ.
  • indirect infection
    °£Á¢°¨¿°.
  • indirect inguinal hernia
    °£Á¢¼­Çý(¼­Çý)Ç츣´Ï¾Æ
  • indirect inhibition
    °£Á¢¾ïÁ¦.
  • indirect laryngoscopy
    °£Á¢Èĵΰæ°Ë»ç(¹ý)
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • indirect auscultation
    °£Á¢Ã»Áø(¹ý).
  • indirect bactericidal test
    °£Á¢»ì±Õ·Â°Ë»ç¹ý
  • indirect bilirubin
    °£Á¢Çü(ÊàïÈúþ)ºô¸®·çºó.
  • indirect cell division
    °£Á¢¼¼Æ÷ºÐ¿­.
  • indirect complement fixation test
    °£Á¢º¸Ã¼°áÇÕ½ÃÇè
  • indirect contact
    °£Á¢Á¢ÃË.
  • indirect contact infection
    °£Á¢Á¢Ã˰¨¿° <Àü¿°>.
  • indirect direct method
    °£Á¢Á÷Á¢¹ý(ÊàïÈòÁ ïÈÛö).
  • indirect fluorescent antibody technique
    °£Á¢Çü±¤Ç×ü¹ý
  • indirect fracture
    °£Á¢ °ñÀý(ÊàïÈÍéï¹).
  • indirect gonioscopy
    °£Á¢Àü¹æ°¢°æ°Ë»ç
  • indirect hemagglutination =IHA
    °£Á¢ÀûÇ÷±¸ÀÀÁý(¹ÝÀÀ)(¡­îåúìϹëêó¢<Úãëë >).
  • indirect hemagglutination test
  • indirect hyperbilirubinemia
  • indirect immunodiffusion
    °£Á¢(ÊàïÈ)¸é¿ªÈ®»ê(Øóæ¹üªß¤)
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 6 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • mass action
    Áú·®ÀÛ¿ë(òõÕáíÂéÄ)
  • mass-action ratio
    Áú·®ÀÛ¿ëÀ²(òõÕáíÂéÄëÒ)
  • photochemical action spectrum
    ±¤È­ÇÐÀÛ¿ë(ÎÃûùùÊíÂéÄ) ½ºÆåÆ®·³
  • photodynamic action
    ±¤¿ªÇÐ ÀÛ¿ë(ÎÃÕôùÊíÂéÄ)
  • protein-sparing action
    ´Ü¹éÁú Àý¾à ÀÛ¿ë(Ó±ÛÜòõï½å³íÂéÄ)
  • specific dynamic action
    ƯÀÌ µ¿Àû ÀÛ¿ë(÷åì¶ÔÑîÜíÂéÄ)
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
PA panic attack; pantothenic acid; paralysis agitans; paranoia; passive aggressive; pathology; patient'...
VAT variable antigen type; ventricular accommodation test; ventricular activation time; vesicular amine ...
Hb Hemoglobin; Ç÷»ö¼Ò; 13 - 15 mg%
  1 gm ÆÄ±«½Ã Indirect Bilirubin 40 mg Áõ°¡
  = ...
IFA test Indirect Fluorescent Antibody test
IHA test Indirect Hem-Agglutination test
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 2
IFAT Indirect Fluorescent Antibody Test
IHA Indirect Haemagglutination
IHA Indirect Haemagglutination Test
IHAT Indirect Haemagglutination Test
IHA Indirect Hemagglutination assay
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • action potential
    Ȱµ¿ ÀüÀ§, Ȱµ¿ Àü¾Ð
    ±ÙÀ°¼¼Æ÷ ¶Ç´Â ½Å°æ¼¼Æ÷°¡ ÈïºÐÇÒ ¶§ »ý±â´Â Àü±âÀû Ȱ¼ºÀ¸·Î¼­, Àü±âÀû, È­ÇÐÀû, ±â°èÀû ÀÚ±Ø ¹× ¿Âµµº¯È­ µî¿¡ ÀÇÇÏ¿© »ý±ä´Ù°í »ý°¢Çϰí ÀÖ´Ù.
  • action variable
    ÀÛ¿ë º¯¼ö
  • adverse action
    À¯ÇØÀÛ¿ë
  • analgetic action
    ÁøÅë ÀÛ¿ë
  • antagonistic action
    ±æÇ× ÀÛ¿ë
  • antidiuretic action
    Ç×ÀÌ´¢ÀÛ¿ë
  • antimicrobial action
    Ç×±Õ ÀÛ¿ë
  • antinociception action
    Ç×Ä§ÇØ¼ö¿ë¼º ÀÛ¿ë, Ç×À¯ÇØ ¼ö¿ë¼º ÀÛ¿ë
  • antipyretic action
    ÇØ¿­ ÀÛ¿ë
  • antispasmodic action
    Áø°æÀÛ¿ë
  • bactericidal action
    »ì±Õ ÀÛ¿ë, »ì±Õ¼º
    1. ¹ÚÅ׸®¾Æ¸¦ Á×ÀÌ´Â Çö»ó. ÀÌ ¿ë¾î´Â Á¾Á¾ Ç×»ýÁ¦ÀÇ ¼º°ÝÀ» ¼³¸íÇϴµ¥ »ç¿ëµÈ´Ù. 2. È­Çпä¹ýÁ¦, ¼Òµ¶Á¦ Áß¿¡´Â ¹Ì»ý¹°À» ¼Ò¸ê½ÃŰ´Â ÀÛ¿ëÀÌ ÀÖ´Ù. ÀÌ¿¡ ´ëÇØ ¾î¶² ¾àÁ¦¿¡ ´ëÇØ ±ÕÀÇ Áõ½ÄÀÌ ¾ïÁ¦µÇ´Âµ¥ ¾àÁ¦¸¦ Á¦°ÅÇÏ¸é ´Ù½Ã Áõ½ÄÇÏ´Â °ÍÀ» Áõ±Õ ÀÛ¿ëÀ̶ó ÇÑ´Ù.
  • bacteriostatic action
    Á¤±Õ ÀÛ¿ë
    ¼¼±ÕÀÇ ¹ßÀ° ¶Ç´Â Áõ½ÄÀ» ¾ïÁ¦ÇÏ´Â ÀÛ¿ë.
  • biological action
    »ý¹° ÀÛ¿ë
  • buffer action
    ¿ÏÃæ ÀÛ¿ë
  • calorigenic action
    ¿­ »ý»ê ÀÛ¿ë
    À½½Ä¹° ¶Ç´Â À½½Ä¹° ¼ººÐ¿¡ ÀÇÇØ ü³»¿¡ ¹ß»ýÇÑ ÃÑ ¿¡³ÊÁö·®.
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
specific action The action of a drug or a method of treatment which has a direct and especially curative effect upon a disease, e.g., the action of vitamin B12 in pernicious anaemia.
(05 Mar 2000)
specific dynamic action The increase of heat production caused by the ingestion of food, especially of protein.
(05 Mar 2000)
delayed-action preparations Dosage forms of a drug that act over a period of time.
(12 Dec 1998)
thermogenic action Increase of heat production of the body, as by the thyroid hormone.
Synonym: thermogenic action.
(05 Mar 2000)
law of mass action <chemistry> This law states that the rate of a given chemical reaction is proportional to concentration of the reactants.
(09 Oct 1997)
calorimetry, indirect Calculation of the energy expenditure in the form of heat production of the whole body or individual organs based on respiratory gas exchange.
(12 Dec 1998)
indirect 1. Not immediate or straight.
2. Acting through an intermediary agent.
Origin: L. Indirectus
(18 Nov 1997)
indirect agglutination Agglutination of particles that have been coated with soluble antigen, by antiserum specific for the adsorbed antigen.
Synonym: indirect agglutination.
(05 Mar 2000)
indirect assay For antibody; an application of the ELISA method in which serum being tested for antibody is added to wells coated with known antigen; presence of antibody bound to the antigen coat can be determined by addition of immunoglobulin-specific antibody to which is linked the enzyme of the indicator system, followed by addition of substrate to the washed aggregate.
(05 Mar 2000)
indirect bilirubin <biochemistry> Free bilirubin that has not been attached to a glucuronide molecule. This results from the rapid breakdown of red blood cells. The haemoglobin molecule is normally converted to bilirubin. Greater than normal values of indirect bilirubin can be seen in erythroblastosis foetalis, haemolytic anaemia, sickle cell anaemia, transfusion reactions, pernicious anaemia and resolution of large haematomas.
(27 Sep 1997)
indirect Coombs' test A test routinely performed in cross-matching blood or in the investigation of transfusion reaction: test for patient's serum is incubated with a suspension of donor erythrocytes; if specific antibodies are present, they become attached to the antigen in donor's cells; after a washing with saline, Coombs' antihuman globulin is added; agglutination at this point indicates that antibodies present in the original test serum had indeed become attached to donor erythrocytes.
(05 Mar 2000)
indirect diuretic A diuretic that acts by increasing cardiac function or by increasing the state of hydration.
(05 Mar 2000)
indirect fluorescent antibody The detection of antibodies to specific antigenic material in the substrate using fluorescent microscopy. Using fluorescent conjugated antibodies which are specific for a particular isotype of antibody, it is possible to distinguish IgG, IgA and IgM isotypes of specific antibodies using indirect fluorescent antibody. This sensitive technique is highly specific in well-trained hands and recent developments in the establishment of internationally recognised standard materials have led to accurate quantitation of antibody concentrations through endpoint titration (the highest serial dilution of specimen at which specific fluorescence remains) and through measuring visual intensity of fluorescence compared to known reference standard material.
(05 Mar 2000)
indirect fracture A fracture, especially of the skull, that occurs at a point not at the site of impact.
(05 Mar 2000)
indirect haemagglutination test A kind of passive agglutination in which erythrocytes, usually modified by mild treatment with tannic acid or other chemicals, are used to adsorb soluble antigen onto their surface, and which then agglutinate in the presence of antiserum specific for the adsorbed antigen.
Synonym: indirect haemagglutination test.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
  • class action
    (°øµ¿ ÇÇÇØÀÚµéÀÇ)Áý´Ü ¼Ò¼Û
  • contact action
    Á¢ÃËÀÛ¿ë
  • covert action(operation)
    (°æÂû.Á¤º¸ºÎÀÇ)ºñ¹Ð°øÀÛ;ºñ¹Ðøº¸È°µ¿
  • cross action
    ¹Ý´ë ¼Ò¼Û;¹Ý¼Ò
  • delaying action
    Áö¿¬ Àü¼ú ÀÇ
  • direct action
    Á÷Á¢ Çൿ ±Ç¸®¸¦ À§ÇÑ ÆÄ¾÷(µ¥¸ð,½Ã¹ÎÀû ÀúÇ× µî)
  • disengaging action
    (±º)±³Àü ȸÇÇ;ÀÚ¹ßÀû ö¼ö
  • evasive action
    (Àü½Ã¿¡ ¼±¹Ú,Ç×°ø±â°¡ ÃëÇÏ´Â)ȸÇÇ Çൿ
  • friendly action
    ¿ìÈ£Àû ¼Ò¼Û
  • industrial action
    ³ëµ¿ÀÚÃøÀÇ ÀïÀÇ ÇàÀ§
  • mass action
    Áú·® ÀÛ¿ë
  • nocover action
    ³ëµ¿ÀïÀÇ ÁßÀÎ Á¶ÇÕ¿ø ¸òÀÇ ÀÏÀ» ÇÏÁö ¾ÊÀ½
  • personal action
    ´ëÀÎ ¼Ò¼Û
  • police action
    ±º´ëÀÇ Ä¡¾È Ȱµ¿;±¹Á¦ ÆòÈ­;Áú¼­ À¯Áö¸¦ À§ÇÑ Á¤±Ô±ºÀÇ Áö¿ªÀûÀÎ ±º»ç Çൿ
  • political action
    Á¤Ä¡Àû ÇàÀ§
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 2
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 2
ÅëÇÕ°Ë»ö ¿Ï·á